[衰老机制的生物标志物]
1Institute of Longevity with Clinic of Rehabilitation and Preventive Medicine - Petrovsky National Research Centre of Surgery, Moscow, Russia.
Voprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury
|December 12, 2025
概括
这项研究提出了一个由30多个生物标志物组成的系统,用于评估衰老机制并指导长寿医学. 它为个性化的衰老率评估和干预提供了参考值和目标值.
科学领域:
- 老年学和长寿医学 老年学和长寿医学
- 生物标志物发现和验证
- 衰老的分子和细胞生物学
背景情况:
- 衰老是一个复杂的过程,由多个相互连接的机制驱动.
- 目前关于衰老生物标志物的知识需要系统化,以便在实践中临床应用.
- 长寿医学旨在通过个性化干预来减缓衰老和延长健康寿命.
研究的目的:
- 巩固和系统化关于基本衰老机制生物标志物的当前知识.
- 确定这些生物标志物的参考值和目标值,用于长寿医学.
- 开发一个全面的生物标志物小组,以进行个性化的衰老评估.
主要方法:
- 对14个关键衰老机制的科学文献进行系统分析.
- 包括既定和新兴的衰老特征,如基因组不稳定性,端粒缩短和表观遗传改变.
- 专注于与细胞衰老,线粒体功能障碍和细胞间通信有关的生物标志物.
主要成果:
- 已经开发出了一个由30多个生物标志物组成的综合系统,包含详细的参考值和目标值.
- 确定的主要生物标志物包括尿中的8-OHdG,白细胞端粒长度,N7-甲基瓜氨酸和自的标志物 (p62,Beclin-1).
- 其他重要的生物标志物包括HOMA-IR,IGF-1,线粒体标志物,与衰老相关的β-galactosidase,炎症细胞因子,微生物群标志物和昼夜生物标志物.
结论:
- 开发的生物标志物小组提供了一种科学验证的方法,用于个性化评估衰老速度.
- 该小组支持纠正与年龄相关的变化,并促进个性化的长寿策略.
- 建议定期监测 (每3-6个月),以有效地解释生物标志物动态和治疗疗效.
相关概念视频
Aging
566
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
566
The Effect of Aging on Tissues
3.1K
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
3.1K
Pharmacodynamics in Geriatric Patients: Effects of Age
175
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
175
Mitochondria
19.5K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
19.5K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
181
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
181
Bone Disorders
5.0K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.0K


